Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic adipose derived mesenchymal stem cell (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
Osteoarthritis (Phase 2)
Osteoarthritis, Knee (Phase 2)
Stroke (Phase 2)
Trials (2 total)
Trial APIs (2 total)